InvestorsHub Logo

JamesF1

01/25/24 5:12 PM

#394470 RE: jour_trader #394469

Nasrat will not over promote generic OxyContin if Elite’s product gets approved. There will certainly be a REMS (risk evaluation) in place for prescribers. Playing by all the rules there is still money to be made. Sadly, there are patients that have legitimate need.